EUVIMEDEUVIMED entdecken
Crossref

Minor Phase Quantification in Octacalcium Phosphate Using Solid‐State 31 P Nuclear Magnetic Resonance Spectroscopy

Toshiisa Konishi iD, Yuka Maruko, Aya Kanauchi, Keizo Hosoya

Journal of Biomedical Materials Research Part B: Applied Biomaterials · 2026-11 · 114 (11)

DOI: 10.1002/jbm.b.70176 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Biomedical Materials Research Part B: Applied Biomaterials, online erschienen am 05.11.2026. Verfasst von Toshiisa Konishi und 3 weiteren Autor:innen. Beteiligte Einrichtung: Materials Technology Group, Tokyo Metropolitan Industrial Technology Research Institute, Tokyo, Japan. Hauptthemen laut MEDLINE: Calcium Phosphates, Durapatite, Bone Substitutes. Die Arbeit nennt 20 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Octacalcium phosphate (OCP) has recently attracted attention as a bone substitute material because of its excellent osteoconductivity. In most cases, the synthesis of OCP is accompanied by precipitation of a secondary phase such as hydroxyapatite (HAp). However, a method for quantifying a secondary phase in OCP has not yet been established, which is a long‐standing issue. This study proposes a method for quantifying the HAp subphase in OCP using solid‐state 31 P nuclear magnetic resonance (NMR) spectroscopy. OCP + HAp powders prepared by the standard‐addition method were used to construct a calibration curve in which the HAp subphase content obtained through peak deconvolution of 31 P‐NMR spectra was plotted. The HAp subphase content in OCP was determined to be 5.3 wt.% with a ±0.4 wt.% uncertainty at a 95% confidence level. The proposed method for quantifying a subphase in OCP using solid‐state 31 P‐NMR would be effective not only for HAp but also for other coprecipitated subphases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Calcium PhosphatesDurapatiteBone SubstitutesMagnetic Resonance SpectroscopyPhosphorus Isotopes

Stichwörter der Autor:innen

hydroxyapatiteoctacalcium phosphatequantificationsolid‐state nuclear magnetic resonancesubphase

Substanzen

octacalcium phosphateCalcium PhosphatesDurapatiteBone SubstitutesPhosphorus Isotopes

Autor:innen und Institutionen

  • Materials Technology Group, Tokyo Metropolitan Industrial Technology Research Institute, Tokyo, Japan.
  • Research & Development Division, Japan Fine Ceramics Co. LTD., Sendai City, Japan.

ORCID-Profile: Toshiisa Konishi

Zitieren

APA

Konishi, T., Maruko, Y., Kanauchi, A., & Hosoya, K. (2026). Minor Phase Quantification in Octacalcium Phosphate Using Solid‐State 31 P Nuclear Magnetic Resonance Spectroscopy. Journal of Biomedical Materials Research Part B: Applied Biomaterials, 114(11). https://doi.org/10.1002/jbm.b.70176

Vancouver

Konishi T, Maruko Y, Kanauchi A, Hosoya K. Minor Phase Quantification in Octacalcium Phosphate Using Solid‐State 31 P Nuclear Magnetic Resonance Spectroscopy. Journal of Biomedical Materials Research Part B: Applied Biomaterials. 2026;114(11). doi:10.1002/jbm.b.70176

BibTeX
@article{Konishi2026,
  author = {Konishi, Toshiisa and Maruko, Yuka and Kanauchi, Aya and Hosoya, Keizo},
  title = {Minor Phase Quantification in Octacalcium Phosphate Using Solid‐State 31 P Nuclear Magnetic Resonance Spectroscopy},
  journal = {Journal of Biomedical Materials Research Part B: Applied Biomaterials},
  year = {2026},
  volume = {114},
  number = {11},
  doi = {10.1002/jbm.b.70176}
}
Kostenlos starten →